Dehydroepiandrosterone sulfate inhibition of catecholamine secretion from bovine adrenal chromaffin cells

Neuroscience Letters

Volumn 204, Issue 3, 1996, Pages 181-184

  Liu, Pei Shan ^a   Lin, Meng Kai ^a   Hsieh, Hsi Lung ^a  

^a SOOCHOW UNIVERSITY   (Taiwan)

Author keywords

Bovine adrenal chromaffin cells; Ca2+ concentration; Cytosolic; Cytosolic Na+ concentration; Dehydroepiandrosterone sulfate; Nicotinic receptor; 3H Norepinephrine secretion

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; NICOTINIC AGENT; NORADRENALIN; PRASTERONE; SODIUM CHANNEL; VERATRIDINE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CATECHOLAMINE RELEASE; CATTLE; CHROMAFFIN CELL; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030049058     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12350-8     Document Type: Article

References (14)

1. Beer, N.A., Jakubowicz, D.J., Beer, R.M. and Nestler, J.E., Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women, J. Clin. Endocrinol. Metab., 79 (1994) 1077-1081.
2. Chasalow, F.I. and Blethen, S.L., Digitalis-like materials and DHEA sulfate. In M. Kalimi and W. Regelson (Eds.), The Biology Role of Dehydroepiandrosterone (DHEA), de Gruyter, Berlin, 1990, pp. 317-330.
3. Goto, A., Yamada, K, Ishii, M., Yoshioka, M., Ishiguro, T. and Sugimoto, T., The effects of urinary digitalis-like factor on cultured vascular smooth muscle cells, Hypertension, 11 (1988) 645-650.
4. 2+ indicators with greatly improved fluorescence properties, J. Biol. Chem., 260 (1985) 3440-3450.
5. + in individual fibroblasts and lymphocytes, J. Biol. Chem., 264 (1989) 19458-19467.
6. Kipatrick, D.L., Ledbetter, F.H., Carson, KA., Kirshner, A.G., Slepetis, R and Kirshner, N., Stability of bovine adrenal medulla cells in culture, J. Neurochem., 35 (1980) 679-692.
7. Kunes, J., Stolba, P., Pohlova, I., Jelinek, J. and Zicha, J., The importance of endogenous digoxin-like factors in rats with various forms of experimental hypertension. Clin. Exp. Hypertension, A7 (1985) 707-712.
8. Nestler, J.E., Beer, N.A., Jakubowicz, D.J., Colombo, C. and Beer, RM., Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men, J. Clin. Endocrinol. Metab., 80 (1995) 700-706.
9. Parker, L.N., Control of adrenal androgen secretion, Endocrinol. Metab. Clin. N. Am., 20 (1991) 401-421.
10. Poston, L., Endogenous sodium pump inhibitors: a role in essential hypertension? Clin. Sci., 72 (1987) 647-655.
11. Schwartz, A., Lindenmayer, G.E. and Allen, J.C., The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects, Pharrmacol. Rev., 27 (1975) 3-134.
12. Vasdev, S., Longerich, L. and Johnson, E., Dehydroepiandrosterone sulfate as a digitalis like factor in plasma of healthy human adults, Res. Commun. Chem. Pathol. Pharmacol., 49 (1985) 387.
13. Wilson, S.P., Purification of adrenal chromaffin cells on renografin gradients, J. Neurosci. Methods, 19 (1987) 163-171.
14. Yamaji T., Ishibashi M., Takaku, F., Itabashi A., Katayama, S. and Ishii, J., Serum dehydroepiandrosterone sulfate concentrations in secondary adrenal insufficiency, J. Clin. Endocrinol. Metab., 65 (1987) 448-451.